Original Air Date 9/27/2022
This
course has expired and is no-longer eligible for CLE.
China is an important jurisdiction that patent protection should be considered, particularly for chemical and pharmaceutical inventions. With more than 30 years of development, China has some unique aspects with respect to patent, which are advisable to be known by patent practitioners to avoid pitfalls when prosecuting in China. This webinar is going to discuss aspects to help patent practitioners to do so, preferably at drafting.
Presented by: Toby Mak, Tee & Howe Intellectual Property Attorneys
AIPLA is an approved provider by most jurisdictions requiring CLE. Each program requires individual jurisdiction approval, and each jurisdiction has different approval guidelines and time frames so programs may not be pre-approved for CLE. Program accreditation is sought in all attendee requested jurisdictions and may be available for up to one year after the original air date. Specialized credits (Ethics, Elimination of Bias, Diversity, Equity & Inclusion, Technology, etc.) approval varies by jurisdiction. CLE reporting and/or certificates of attendance may take up to 4 weeks for processing.
For information on CLE accreditation and processing, please contact the AIPLA CLE Department at cle@aipla.org.